Mankind Pharma IPO Opens to a Slow Start, Subscribed Only 6% on Day 1
Day 1 subscription of Mankind Pharma IPO at 4%: Investors take a cautious approach
Day 1 subscription of Mankind Pharma IPO at 4%: Investors take a cautious approach
